Skip to main content
Log in

Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

To study the changes in intratumoral microvessel density (MVD) in hepatocellular carcinoma (HCC) following transcatheter arterial chemoembolization (TACE), MVD in 42 HCC specimens histologically verified was studied by using immunohistochemical method. Of all the specimens, 20 were obtained from the patients treated with surgical resection alone, 22 from those with second stage surgical resection after TACE. The results showed that the MVD in HCC tissues was 53. 4±21. 9 in the TACE group and 27. 6±9. 2 in the single operating group, respectively, with the difference being significant between them (P<0. 001). It was suggested that TACE might contribute to angiogenesis of HCC, possibly due to anoxic stress and ischemia-reperfusion injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Araya M, Terashima M, Takagane Aet al. Microvessel count predicts metastasis and prognosis in patients with gastric cancer. J Surg Oncol, 1997, 65:232

    Article  CAS  PubMed  Google Scholar 

  2. Tanigawa N, Lu C, Mitsui Tet al. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology, 1997, 26:1216

    CAS  PubMed  Google Scholar 

  3. Sun H C, Tang Z Y, Li X Met al. Microvessel density of hepatocellular carcinoma: its relationship with prognosis. J Cancer Res Clin Oncol, 1999, 125:419

    Article  CAS  PubMed  Google Scholar 

  4. 1999,33(3):153

  5. Kobayashi N, Ishii M, Ueno Yet al. Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization. Liver, 1999, 19:25

    Article  CAS  PubMed  Google Scholar 

  6. Kim KM, Bae SK, Lee OHet al. Insulin-like growth factor I induced by hypoxia may contribute to angiogenesis of hepatocellular carcinoma. Cancer Res, 1998, 58: 348

    CAS  PubMed  Google Scholar 

  7. Colletti L M, Remick D G, Burtch GDet al. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest, 1990, 85:1936

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Yamaguchi R, Yano H, Iemura Aet al. Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology, 1998, 28:68

    Article  CAS  PubMed  Google Scholar 

  9. Prewett M, Huber J, Li Yet al. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res, 1999, 59:5209

    CAS  PubMed  Google Scholar 

  10. Drixler T A, Rinkes I H, Ritchie EDet al. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastasis after partial hepatectomy. Cancer Res, 2000, 60:1761

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jilin, Y., Xiaofeng, L., Zhifang, Y. et al. Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization. Current Medical Science 21, 321–322 (2001). https://doi.org/10.1007/BF02886568

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02886568

Key words

Navigation